Trials / Conditions / Aggressive B-Cell Non-Hodgkin Lymphoma
Aggressive B-Cell Non-Hodgkin Lymphoma
4 registered clinical trials studyying Aggressive B-Cell Non-Hodgkin Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Th NCT07432022 | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265 | Verismo Therapeutics | Phase 1 |
| Active Not Recruiting | ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma NCT05025800 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Unknown | A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma NCT05840289 | University Hospital, Geneva | — |